article_metadata: Peter Bentham Roger T Staff Bjoern O Schelter Helen Shiells Charles R Harrington Claude M Wischik
article_metadata: 10.3233/JAD-210390
article_metadata: J Alzheimers Dis
article_metadata: 2021;83(3):1017-1023.
article_metadata: frontotemporal dementia p301s hydromethylthionine leucomethylthioninium microtubule-associated protein tau
article_metadata: CC BY
article_metadata: https://pubmed.ncbi.nlm.nih.gov/34366349/
article_metadata: Atrophy / pathology Atrophy / prevention & control Carrier State Frontotemporal Dementia / drug therapy Frontotemporal Dementia / genetics Methylene Blue / analogs & derivatives Mutation / genetics tau Proteins / genetics
article_metadata: Atrophy / pathology Atrophy / prevention & control Carrier State Frontotemporal Dementia / drug therapy Frontotemporal Dementia / genetics Methylene Blue / analogs & derivatives Mutation / genetics tau Proteins / genetics Case Reports Letter Adult Brain / pathology Humans Magnetic Resonance Imaging Male Methylene Blue / administration & dosage Time Factors MAPT protein, human tau Proteins hydromethylthionine Methylene Blue
article_metadata: PMC8543267
article_metadata: 34366349
article_metadata: Long-Term Hydromethylthionine Treatment Is Associated with Delayed Clinical Onset and Slowing of Cerebral Atrophy in a Pre-Symptomatic P301S MAPT Mutation Carrier
article_metadata: 2021